TRAW

0.175023.91%
JE

Jack E. Stover

Independent Chairman

Mr. Jack E. Stover, CPA, serves as Director at Profusa, Inc. since July 11, 2025 and serves as Chief Executive Officer & Executive Chairman since July 21, 2026. He is Independent Director at TransCode Therapeutics, Inc. from December 2025. He has been a member of the board of directors of Stero Therapeutics, Inc. since February 2024. Mr. Stover served as Director at PharmaCyte Biotech, Inc. from August 15, 2022, until November 1, 2022, where he was also appointed chairman of the audit committee. He co-founded NorthView Acquisition Corporation and served as its Chief Executive Officer and Director from April 19, 2021, to July 2025. Since November 2018, Mr. Stover has been director and served as Lead Independent Director of Traws Pharma Inc. (formerly Onconova Therapeutics, Inc.), a Nasdaq-based company focused on small molecule anti-viral and oncology therapeutics. Onconova Therapeutics, Inc. (Nasdaq: ONTX) merged with Trawsfynydd Therapeutics, Inc. to become Traws Pharma Inc. in March 2024. He has also served as Independent Director of Traws Pharma, Inc. since May 23, 2016 and as its Chairman since April 15, 2025. Mr. Stover has been Chief Executive Officer of Zebec Therapeutics LLC (Zebec) since September 2013, which is the successor to Quadrant Pharmaceuticals LLC, a company he co-founded and served as President and Director since September 2013. He served as the Chief Executive Officer and President of Interpace Biosciences, Inc. (formerly Interpace Diagnostics Group, Inc.) from June 21, 2016, until December 1, 2020 and as Interim Chief Executive Officer and Interim President from December 22, 2015, until June 20, 2016. He was also on the board of directors of Interpace Biosciences, Inc. from August 9, 2005, until December 1, 2020. From 2009 to February 2012, Mr. Stover served as the Executive Chairman of Targeted Nano Therapeutics LLC. He serves as Consultant at Interpace Biosciences, Inc. Mr. Stover served as the Chief Executive Officer at Antares Pharma Inc. from September 1, 2004, to October 2008, Chief Operating Officer from July 2004 to September 1, 2004, President from July 22, 2004, to July 2008 and Vice Chairman and Executive Director until October 2008. Prior to Antares Pharma, he served as Executive Vice President, Chief Financial Officer and Treasurer of SICOR Inc. from April 2002 to August 12, 2003. He also served as Chief Operating and Financial Officer of Gynetics Inc. from 1998 to 2000 and from 1993 to 1998, he was Executive Vice President of Gynetics Inc., Senior Vice President, Chief Information Officer and Chief Financial Officer of B. Braun Medical Inc. Mr. Stover was a Partner of Crawford Capital HealthTech Ventures II, L.P. and Crawford Capital. From 1975 to 1993, he was employed by PricewaterhouseCoopers LLP (formerly Coopers & Lybrand), where he became Partner in 1985 and was Partner-in-Charge for the LifeSciences Practice in New Jersey, delivering advisory services to medical and biotechnology clients. While at PricewaterhouseCoopers, Mr. Stover worked in the bioscience industry division in New Jersey. From 2001 to 2002, he was a Venture Partner for Sarnoff Corp. He served as Director of Cernostics, Inc. from March 2015 until July 2016, Director of Viatar CTC Solutions Inc. from July 1, 2016, Director at JE Stover Consulting, LLC from 2008 to 2015, Director of Arbios Systems Inc. from 2005 to 2008 and Director of Influmedix, Inc. from 2010 to 2011. From 2005 to 2015, he served as a Member of the Board of Directors at PDI Inc. He has served as Director for several healthcare companies, including B. Braun Medical Inc. and Gynetics Inc. Mr. Stover holds a B.S. in Business and a B.A. in Accounting from Lehigh University (1975) and is a licensed Certified Public Accountant.

Positions